© The Financial Times Ltd 2014 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Mar 08, 2014, the consensus forecast amongst 19 polled investment analysts covering PT Kalbe Farma Tbk advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Dec 07, 2012. The previous consensus forecast advised investors to hold their position in PT Kalbe Farma Tbk.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 13 analysts offering 12 month price targets for
|Div growth (TTM)||+35.71 %|
On Oct 29, 2013,
The next earnings announcement is expected on Mar 25, 2014. View Full Interim Financials
|Average growth rate||+88.70 %|
The next earnings announcement from
|Average growth rate||+27.10 %|
PT Kalbe Farma Tbk had 3rd quarter 2013 revenues of 4.02bn. This bettered the 4.01bn consensus of the 2 analysts covering the company. This was 2.22% above the prior year's 3rd quarter results. View Full Interim Financials
|Average growth rate||+4.41 %|
PT Kalbe Farma Tbk had revenues for the full year 2012 of 13.64bn. This was 24.97% above the prior year's results. View Full Annual Financials
|Average growth rate||+14.89 %|